Table 3 Baseline characteristics of 5332 male and 7573 female pairs matched by propensity scores.
Checkups | No kidney test and no checkupa | ASD | ||
|---|---|---|---|---|
Men | Number | 5332 | 5332 | |
Age, years | 69 (62–74) | 68 (62–74) | 0.019 | |
Use of anti-diabetic drugs, n (%) | 111 (2.1) | 105 (2.0) | 0.008 | |
anti-hypertensive drugs | 858 (16.1) | 828 (15.5) | 0.015 | |
lipid-lowering drugs | 275 (5.2) | 203 (3.8) | 0.065 | |
anti-platelet drugs | 395 (7.4) | 278 (5.2) | 0.090 | |
Women | Number | 7573 | 7573 | |
Age, years | 68 (63–74) | 68 (60–77) | < 0.001 | |
Use of anti-diabetic drugs, n (%) | 158 (2.1) | 110 (1.5) | 0.048 | |
anti-hypertensive drugs | 1,092 (14.4) | 1,098 (14.5) | 0.002 | |
lipid-lowering drugs | 436 (5.8) | 451 (6.0) | 0.008 | |
anti-platelet drugs | 416 (5.5) | 338 (4.5) | 0.047 |
